Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Lucid Diagnostics (LUCD) Gross Profit (2021 - 2025)

Lucid Diagnostics (LUCD) has disclosed Gross Profit for 5 consecutive years, with $4.5 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Gross Profit rose 255.17% year-over-year to $4.5 million, compared with a TTM value of $4.9 million through Sep 2025, up 138.65%, and an annual FY2024 reading of -$2.8 million, up 79.97% over the prior year.
  • Gross Profit was $4.5 million for Q3 2025 at Lucid Diagnostics, up from -$5.4 million in the prior quarter.
  • Across five years, Gross Profit topped out at $6.5 million in Q4 2024 and bottomed at -$5.4 million in Q2 2025.
  • Average Gross Profit over 5 years is -$930107.9, with a median of -$1.1 million recorded in 2023.
  • The sharpest move saw Gross Profit tumbled 4118.42% in 2023, then surged 293.32% in 2024.
  • Year by year, Gross Profit stood at $444273.0 in 2021, then increased by 8.27% to $481000.0 in 2022, then crashed by 800.21% to -$3.4 million in 2023, then soared by 293.32% to $6.5 million in 2024, then plummeted by 31.27% to $4.5 million in 2025.
  • Business Quant data shows Gross Profit for LUCD at $4.5 million in Q3 2025, -$5.4 million in Q2 2025, and -$723000.0 in Q1 2025.